Rashid et al. [27] demonstrated that ALPK1 mutation (V1092A) at the C-terminus in spiradenoma and spiradenocarcinoma can activate NF-κB signaling in cell reporter systems. The gene discussed is ALPK1; the disease is benign spiradenoma.